Australia's TGA Clears CSL's H1N1 Vaccine For Young Children
This article was originally published in PharmAsia News
Executive Summary
Australia's Therapeutic Goods Administration has approved CSL's Panvax H1N1 flu vaccine for children between three years old and 10 years old